Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a

Emmelie Cansby1, Manoj Amrutkar, Louise Mannerås Holm

  • 1The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, University of Gothenburg, Blå stråket 5, SE-41345 Gothenburg, Sweden.

Insights

Overexpression of serine/threonine protein kinase 25 (STK25) impairs glucose tolerance and insulin sensitivity. This metabolic shift promotes lipid storage over oxidation, contributing to systemic insulin resistance, particularly under high-fat diet conditions.

Area of Science:

  • Metabolic regulation
  • Molecular biology
  • Physiology

Background:

  • Serine/threonine protein kinase 25 (STK25) is a Ste20 superfamily kinase.
  • Partial STK25 depletion enhances lipid oxidation and glucose uptake in myoblasts.

Purpose of the Study:

  • To investigate the role of STK25 overexpression in metabolic dysfunction.
  • To determine the impact of STK25 on glucose tolerance and insulin sensitivity in vivo.

Main Methods:

  • Generation of STK25 transgenic mice.
  • High-fat diet challenge.
  • Glucose and insulin tolerance tests.
  • Euglycemic-hyperinsulinemic clamp studies.
  • Analysis of gene expression in skeletal muscle and liver.

Main Results:

  • STK25 transgenic mice exhibited reduced glucose tolerance and insulin sensitivity.
  • Fasting plasma insulin levels were elevated in transgenic mice.
  • Energy expenditure decreased, while hepatic lipid and glycogen stores increased.
  • Skeletal muscle oxidative capacity was diminished, with altered expression of key metabolic enzymes.

Conclusions:

  • Overexpression of STK25 promotes a metabolic shift towards lipid storage and away from oxidation.
  • This shift contributes to systemic insulin resistance, especially under conditions of excess dietary fuel.
  • STK25 plays a critical role in regulating metabolic balance and insulin sensitivity.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...